Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:35 pm Sale |
2024-09-30 | 13G | Unity Biotechnology, Inc. UBX |
Alyeska Investment Group, L.P. | 1,667,914 9.990% |
-8,904 (-0.53%) |
Filing History |
| 2024-02-14 1:52 pm Purchase |
2023-12-31 | 13G | Unity Biotechnology, Inc. UBX |
Alyeska Investment Group, L.P. | 1,676,818 9.990% |
257,818 (+18.17%) |
Filing History |
| 2023-05-10 09:45 am Sale |
2023-05-09 | 13G | Unity Biotechnology, Inc. UBX |
FMR CORP | 600,004 4.016% |
-763,116 (-55.98%) |
Filing History |
| 2023-02-14 2:07 pm Purchase |
2022-12-31 | 13G | Unity Biotechnology, Inc. UBX |
Alyeska Investment Group, L.P. | 1,419,000 9.990% |
1,419,000 (New Position) |
Filing History |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Unity Biotechnology, Inc. UBX |
FMR CORP | 1,363,120 9.215% |
1,363,120 (New Position) |
Filing History |
| 2022-10-11 09:03 am Purchase |
2022-10-07 | 13G | Unity Biotechnology, Inc. UBX |
FMR CORP | 1,354,322 9.658% |
22,000 (+1.65%) |
Filing History |
| 2022-09-12 11:13 am Purchase |
2022-09-09 | 13G | Unity Biotechnology, Inc. UBX |
FMR CORP | 1,332,322 14.975% |
1,021,669 (+328.88%) |
Filing History |
| 2022-02-14 4:12 pm Unchanged |
2021-12-31 | 13G | Unity Biotechnology, Inc. UBX |
Venrock Associates VII L.P. | 268,004 4.600% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:55 pm Purchase |
2021-12-31 | 13G | Unity Biotechnology, Inc. UBX |
ARCH Venture Fund VII L.P. | 1,013,886 17.500% |
3,856 (+0.38%) |
Filing History |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Unity Biotechnology, Inc. UBX |
FMR CORP | 310,653 5.381% |
-147,709 (-32.23%) |
Filing History |
| 2021-07-01 11:12 am Sale |
2021-06-30 | 13G | Unity Biotechnology, Inc. UBX |
BAILLIE GIFFORD & CO | 247,907 4.520% |
-132,395 (-34.81%) |
Filing History |
| 2021-06-09 2:01 pm Sale |
2021-05-31 | 13G | Unity Biotechnology, Inc. UBX |
BLACKROCK INC BLK |
271,148 4.900% |
-17,017 (-5.91%) |
Filing History |
| 2021-02-08 10:35 am Sale |
2021-02-05 | 13G | Unity Biotechnology, Inc. UBX |
FMR CORP | 458,362 8.662% |
-26,737 (-5.51%) |
Filing History |
| 2021-02-02 5:03 pm Purchase |
2020-12-31 | 13G | Unity Biotechnology, Inc. UBX |
ARCH Venture Fund VII L.P. | 1,010,030 19.100% |
3,856 (+0.38%) |
Filing History |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | Unity Biotechnology, Inc. UBX |
BLACKROCK INC BLK |
288,165 5.400% |
288,165 (New Position) |
Filing History |
| 2021-01-14 12:29 pm Unchanged |
2020-12-31 | 13G | Unity Biotechnology, Inc. UBX |
BAILLIE GIFFORD & CO | 380,301 7.190% |
0 (Unchanged) |
Filing History |
| 2021-01-08 4:49 pm Purchase |
2018-12-31 | 13G | Unity Biotechnology, Inc. UBX |
WuXi PharmaTech Healthcare Fund I L.P. | 147,799 2.800% |
147,799 (New Position) |
Filing History |